Switchboard Health acquires Livara Health to add virtual musculoskeletal care

The acquisition moves Switchboard beyond specialty-care navigation into direct care delivery by integrating Livara’s virtual-first, value-based MSK model, alongside more than $5 million in new financing.

Switchboard Health has acquired Livara Health, combining its specialty referral and care-navigation platform with Livara’s virtual orthopaedic and musculoskeletal care model for health plans, providers and employers.

Alongside the acquisition, Switchboard closed an oversubscribed equity financing of more than $5 million to support its expansion into care delivery and further growth.

Field	Content
Alert Type	Deal
Companies	Switchboard Health; Livara Health
Deal Type	Acquisition with concurrent equity financing
Asset or Company	Livara Health
Therapy Area(s)	Musculoskeletal care; Orthopaedics; Physical therapy
Technology or Modality	Virtual care; Value-based healthcare; Care navigation; Digital health
Deal Value	Acquisition terms were not disclosed. In conjunction with the transaction, Switchboard closed an oversubscribed equity financing of more than $5 million. The financing included existing Switchboard and Livara investors as well as new backers including First Trust Capital Partners, Route 66 Ventures, A1 Health Ventures, Allumia Ventures and Martin Ventures. (Switchboard Health)
Development Stage	Commercial
Geography	United States
What Happened	On 25 August 2026, Switchboard Health announced the acquisition of Livara Health, formerly known as SpineZone, a virtual-first MSK management company. Switchboard will integrate Livara’s virtual MSK programme into its referral-management and automated care-navigation platform, allowing provider and health-plan customers to enrol eligible patients directly into Livara care. The deal marks an expansion of Switchboard’s business model from connecting patients with specialty providers to also delivering care. (Switchboard Health)
Why It Matters	The acquisition gives Switchboard an established clinical-care capability rather than limiting its role to referral and navigation infrastructure. Livara combines care planning, virtual treatment and navigation using a multidisciplinary model involving physicians, physical therapists and psychosocial providers, including services for complex and higher-cost MSK patients. (Switchboard Health)
Supporting Context	Switchboard cites an independent 2024 Validation Institute review reporting that participants in Livara’s programme achieved a 43% reduction in musculoskeletal spending, driven largely by lower surgical utilisation. Switchboard also reported that patient volumes moving through its own platform have increased 500% over the past nine months, providing the commercial backdrop for its expansion into direct care delivery. (Switchboard Health)
Strategic Rationale	Switchboard can combine its existing referral-management infrastructure and provider relationships with Livara’s clinical MSK services, creating a more integrated pathway from patient identification and referral through virtual treatment. Livara gains access to Switchboard’s provider and health-plan distribution channels, potentially allowing its MSK model to reach a larger patient population.
Potential Impact	The combination could enable Switchboard to capture a larger part of the specialty-care pathway while giving health plans and risk-bearing providers a single platform for identifying, navigating and treating MSK patients. The commercial impact will depend on successful integration and adoption of Livara services across Switchboard’s existing customer base.
Key Takeaway	The Livara acquisition transforms Switchboard from primarily a specialty-care navigation platform into a company that can also directly deliver virtual MSK care.
What to Watch	Integration of Livara into Switchboard’s platform, adoption among existing provider and health-plan customers and how Switchboard deploys the $5 million-plus financing to expand its care-delivery capabilities.
Primary Source	Switchboard Health acquisition announcement
Relevant Date	25 August 2026

---

Discover how nuaxia can support your next medical education initiative:

• Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector 

• Contact us on: support@nuaxia.com